<DOC>
	<DOCNO>NCT02539654</DOCNO>
	<brief_summary>The purpose study describe pharmacokinetics ( PK ) EXE844 Sterile Otic Suspension , 0.3 % follow single bilateral ototopical dose pediatric subject , immediately bilateral tympanostomy tube surgery .</brief_summary>
	<brief_title>Pediatric Pharmacokinetic ( PK ) Study EXE844 Otic Suspension Otitis Media Time Tympanostomy Tube Insertion ( OMTT )</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<criteria>Recurrent acute otitis medium ( RAOM ) chronic otitis medium effusion ( COME ) eligible bilateral myringotomy tympanostomy tube insertion ; Legally Authorized Representative ( LAR ) must read sign informed consent ; Parent caregiver must agree complete require study visit comply requirement study ; Other protocolspecified inclusion criterion amy apply . Menarcheal females ; Previous otologic otologicrelated surgery within past 30 day ongoing complication ; Existing perforation eardrum ; Current acute otitis externa ( AOE ) , malignant otitis externa ( MOE ) condition could interfere evaluation study drug ; Any systemic disease disorder , complicate factor structural abnormality would negatively affect conduct outcome study ; Use prohibit medication inadequate washout medication include systemic topical antibiotic , steroid and/or analgesic ; Weighs le 8 kg ; Other protocolspecified exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>